Chronic allograft nephropathy: A prospective randomised trial of cyclosporin deduction with or without mycophenolate mofetil

被引:8
|
作者
Jain, S [1 ]
Metcalfe, M [1 ]
White, SA [1 ]
Furness, PN [1 ]
Nicholson, ML [1 ]
机构
[1] Leicester Gen Hosp, Dept Transplant Surg, Leicester LE5 RPW, Leics, England
关键词
D O I
10.1016/S0041-1345(01)01928-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:2165 / 2166
页数:2
相关论文
共 50 条
  • [31] Mycophenolate mofetil decreases the risk for chronic renal allograft failure
    Meier-Kriesche, HU
    Ojo, AO
    Arndorfer, JA
    Magee, JC
    Cibrik, DM
    Leichtman, AB
    Campbell, DA
    Kaplan, B
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1005 - 1006
  • [32] Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil
    Merville, P
    Bergé, F
    Deminière, C
    Morel, D
    Chong, G
    Durand, D
    Rostaing, L
    Mourad, G
    Potaux, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1769 - 1775
  • [33] Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy
    Pretagostini, R
    Rossi, M
    Colonnello, M
    Novelli, G
    Berloco, P
    Venettoni, S
    Cortesini, R
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1025 - 1026
  • [34] Long term outcome of mycophenolate mofetil addition to cyclosporine in kidney transplant recipients with chronic allograft nephropathy.
    Urbanowicz, Arkadiusz L.
    Perkowska, A.
    Cieciura, T.
    Baczkowska, T.
    Pazik, J.
    Nowacka-Cieciura, E.
    Szmidt, J.
    Chmura, A.
    Durlik, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 446 - 446
  • [35] Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial
    Duan, Yajuan
    Bai, Yu
    Guo, Weikang
    Wang, Liyan
    Dai, Wendi
    Guo, Wang
    Huang, Hongdong
    Liu, Wenhu
    Diao, Zongli
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (01) : 95 - 102
  • [36] Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
    Neurath, MF
    Wanitschke, R
    Peters, M
    Krummenauer, F
    zum Büschenfelde, KHM
    Schlaak, JF
    GUT, 1999, 44 (05) : 625 - 628
  • [37] Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus
    Daly, I
    Jain, A
    Reyes, J
    Fung, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1503 - 1503
  • [38] Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function
    Fritsche, L
    Sperschneider, H
    Budde, K
    Giessing, M
    Türk, H
    Böhler, T
    Schröder, K
    Stein, G
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2229 - 2229
  • [39] Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection
    Kato, T
    Ruiz, P
    DeFaria, W
    Weppler, D
    Khan, F
    Pinna, A
    Nery, J
    Tzakis, A
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 396 - 396
  • [40] Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction
    Islam, MS
    Francos, GC
    Dunn, SR
    Burke, JF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2230 - 2231